aTyr Pharma, Inc. (ATYR NASDAQ) stock market data APIs
$1.0245
0.04(3.9%)
as of September 17, 2025
Try our APIs with
free plan!
aTyr Pharma, Inc. Financial Data Overview
Price chart is built with
Anychart
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Prev. Close
1.0245
Open
1.0633
High
1.0825
Low
0.9753
52 wk Range
0.969-7.29
Market Cap
100 M
Shares Outstanding
97 987 K
EPS
-0.22
Beta
1.011
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with aTyr Pharma, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get aTyr Pharma, Inc. data using free add-ons & libraries
Get aTyr Pharma, Inc. Fundamental Data
aTyr Pharma, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -69 363 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: -0.1827
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
aTyr Pharma, Inc. News
New
aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman
SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that i...
INVESTOR ALERT: Investigation of aTyr Pharma, Inc. (ATYR) Announced by Holzer & Holzer, LLC
ATLANTA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) complied with federal securities laws. O...
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; aTyr Pharma, Oracle to Advance
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mostly higher hours before T PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Se PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
